AOBiome Therapeutics


    AOBiome is a Boston based biotech company focused on transforming human health through products that restore ammonia-oxidizing bacteria (AOBs) which current hygiene practices have stripped from the modern microbiome. Founded in 2013 by MIT Chemical Engineer David Whitlock and Patients Like Me founder Jamie Heywood along with co-founders Hilly Thompson and Lenny Barshack. The company is developing a novel class of therapeutics to improve skin health, hypertension, and other systemic conditions.